ARRAY Technologies, Inc. Reports Financial Results for the Third Quarter 2025

ARRAY Technologies, Inc. Reports Financial Results for the Third Quarter 2025 GlobeNewswire November 05, 2025 Exceptional momentum continues with year-to-date revenue up 65% and volume up 74% 2025 Third Quarter Highlights Successfully completed acquisition of APA Solar (APA), a leading provider of foundations, fixed-tilt and solar racking solutions Total executed contracts and awarded orders at […]

Alto Ingredients, Inc. Reports Third Quarter 2025 Results

(NASDAQ:ALTO), PEKIN, Ill., Nov. 05, 2025 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter ended September 30, 2025. “Our 2025 initiatives to target high-return market segments, boost operational efficiency and achieve cost savings have strengthened

Lightbridge Provides Business Update and Announces Third Quarter 2025 Financial Results

Lightbridge Provides Business Update and Announces Third Quarter 2025 Financial Results GlobeNewswire November 05, 2025 RESTON, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the third quarter and nine months ended September 30, 2025, and provided an

Noodles & Company Announces Third Quarter 2025 Financial Results

(NASDAQ:NDLS), BROOMFIELD, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced financial results for its third quarter ended September 30, 2025. Key highlights for the third quarter of 2025 versus the third quarter of 2024 include: Total revenue decreased 0.5% to $122.1 million from $122.8 million in the third quarter

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire November 05, 2025 3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA(1) of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjusted Net Income(2)

Interparfums, Inc. Reports 2025 Third Quarter Results

Interparfums, Inc. Reports 2025 Third Quarter Results FY2025 Guidance Refined to Reflect Market Dynamics GlobeNewswire November 05, 2025 NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the third quarter and nine months ended September 30, 2025. Financial Highlights:($ in millions, except per share amounts) Three Months

NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results

(NASDAQ:NXTC), BELTSVILLE, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer, today provided a business update and reported third quarter 2025 financial results. “We have made significant progress advancing our promising ADC programs,” said Michael Richman,

Rapport Therapeutics to Participate in Upcoming Investor Conferences

(NasdaqGM:RAPP), BOSTON and SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to participate in the following upcoming investor events:

CVRx Reports Third Quarter 2025 Financial and Operating Results

CVRx Reports Third Quarter 2025 Financial and Operating Results GlobeNewswire November 05, 2025 MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the third quarter

Workhorse Group Sets Third Quarter 2025 Earnings Call for Tuesday, November 11, 2025 at 10:00 a.m. ET

(NASDAQ:WKHS), CINCINNATI, Nov. 05, 2025 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, will hold a conference call on Tuesday, November 11th at 10:00 a.m. Eastern time (7:00 a.m. Pacific time) to discuss its financial results for the

Scroll to Top